Medical radiation safety market seen reaching $3.46 billion by 2030

The Business Research Company projects the medical radiation detection, monitoring and safety market will rise from $2.4 billion in 2026 to $3.46 billion by 2030, driven by imaging growth, radiation therapy demand and tighter safety standards. North America is expected to lead in 2025, while Asia-Pacific is forecast to grow fastest.

Why it matters: - More medical procedures now rely on radiation, which raises demand for tools that monitor exposure and protect patients and staff. - The market outlook points to sustained spending on safety technology across hospitals, imaging centers and nuclear medicine settings.

What happened: - The Business Research Company published a report on the global medical radiation detection, monitoring and safety market on Aug. 19, 2026. - The report estimates the market will grow from $2.18 billion in 2025 to $2.4 billion in 2026. - The report forecasts the market will reach $3.46 billion by 2030. - The company projects a 10.1% CAGR from 2025 to 2026 and a 9.6% CAGR through 2030. - A free sample of the report is available online. - The full market report is also available online.

The details: - Medical radiation detection, monitoring and safety devices identify radiation levels and help limit harmful exposure in healthcare settings. - The report says historical growth has been driven by more diagnostic imaging, greater use of radiation therapies, stricter radiation-monitoring rules, hospital safety programs and dosimetry standards. - Looking ahead, growth is expected to come from investment in imaging infrastructure, more focus on occupational radiation safety, expansion of nuclear medicine, smart monitoring technologies and detector improvements. - The report highlights a trend toward real-time radiation monitoring systems, more advanced personal dosimetry devices, integrated safety solutions, portable detection equipment and stronger protection for staff and patients. - Cancer remains a major demand driver because radiation therapy and nuclear medicine often require exposure to radioactive substances. - In February 2025, Cancer Australia reported 4,641 new pancreatic cancer cases in 2024, including 2,414 males and 2,227 females. - The report says North America is expected to hold the largest market share in 2025. - The Asia-Pacific region is projected to grow fastest over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market’s growth rate is strong, but the bigger signal is the mix of forces behind it: more imaging volume, more therapy use and more regulatory pressure to manage exposure. - The rise of portable and real-time monitoring tools suggests buyers want systems that fit faster, more distributed care settings, not just legacy hospital environments.

What's next: - Hospitals, imaging providers and device makers are likely to keep investing in radiation safety hardware and software as procedures expand. - The fastest gains will likely come in regions and specialties where imaging and nuclear medicine adoption are still increasing. - The report’s forecast implies continued demand for detector upgrades, personal dosimetry and integrated safety platforms through 2030.